COMMUNIQUÉS West-GlobeNewswire
-
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
02/06/2026 -
Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
02/06/2026 -
Scene Health Releases New Guide on Medication Adherence Support for Leaders Advancing Rural Health Transformation
02/06/2026 -
USOSM Supports OMS Foundation Through 2026 Matching-Gift Incentive
02/06/2026 -
Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
02/06/2026 -
Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally
02/06/2026 -
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
02/06/2026 -
OncoBag launches innovative handbag for post-mastectomy women
02/06/2026 -
New Study: Baby Gut Microbiome Differences Linked to Eczema and Food Allergy Emerge by 6 Months
02/06/2026 -
Myriad Genetics Names Raj Jampa as New Chief Technology Officer
02/06/2026 -
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
02/06/2026 -
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
02/06/2026 -
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
02/06/2026 -
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure
02/06/2026 -
TOMI Environmental Eyes Massive Expansion Opportunity as Food Industry Seeks Advanced Protection Against Emerging Pathogens
02/06/2026 -
The Ensign Group Acquires Real Estate and Operations in Iowa
02/06/2026 -
TG Therapeutics to Participate in the Goldman Sachs 47th Annual Healthcare Conference
02/06/2026 -
Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096
02/06/2026 -
Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain
02/06/2026
Pages